Date
Title
October 19, 2018

Prediction of irAEs in Ipilimumab-treated melanoma patients based on serum autoantibodies

–European Society for Medical Oncology (ESMO) 2018
October 01, 2018

Potential utility of a positive EarlyCDT®—Lung blood biomarker test in indeterminate pulmonary nodules.

–Journal of Thoracic Oncology
September 30, 2018

Development and validation of an ELISA test detecting a panel of autoantibodies in combination with AFP for early detection of hepatocellular carcinoma.

–ILCA, London
August 01, 2018

Label-free microarray-based detection of autoantibodies in human serum

–Journal of Immunological Methods
May 22, 2018

Cost-effectiveness of an autoantibody test (EarlyCDT®—Lung ) as an aid to early diagnosis of lung cancer in patients with incidentally detected pulmonary nodules.

–PLOS One
January 01, 2018

The RA-MAP Consortium: a working model for academia–industry collaboration

–Nature Reviews Rheumatology
January 01, 2018

Bicaudal D2 is a novel autoantibody target in systemic sclerosis that shares a key epitope with CENP-A but has a distinct clinical phenotype

–Autoimmunity Reviews
December 01, 2017

High diagnostic accuracy of histone H4-IgG autoantibodies in systemic lupus erythematosus

–Rheumatology
November 03, 2017

Autoantibody profiling in Prostvac and Ipilimumab treated prostate cancer patients reveals potential biomarkers of immune-related adverse events

–American College of Rheumatology (ACR) annual meeting 2017
November 03, 2017

Differential diagnosis of autoimmune diseases, outlier detection plus subgrouping in clinical trials by high content autoantibody profiling

–American College of Rheumatology (ACR) annual meeting 2017
November 03, 2017

Development of a multimarker model for the detection of systemic lupus erythematosus based on new and traditional autoantibodies

–American College of Rheumatology (ACR) annual meeting 2017
November 01, 2017

Determination of the detection lead time for autoantibody biomarkers in early stage lung cancer using the UKCTOCS cohort.

–Journal of Thoracic Oncology
October 13, 2017

Changes in smoking behaviour in the Early Cancer detection test Lung cancer Scotland (ECLS) study.

–Journal of Thoracic Oncology
October 12, 2017

Is lung cancer screening associated with a negative psychological impact?

–Journal of Thoracic Oncology
October 03, 2017

How does screening for the early detection of lung cancer facilitate smoking cessation? A qualitative study of screened smokers.

–Journal of Thoracic Oncology
September 12, 2017

Autoantibodies as additive biomarkers to AFP for the detection of HCC.

–11th Annual International Liver Cancer Association (ILCA)
September 01, 2017

An interim report on the detection in blood of autoantibodies to tumour antigens as a case-finding method in lung cancer using the EarlyCDT®—Lung Test in Scotland (ECLS).

–European Respiratory Journal
June 14, 2017

Diagnostic modeling of systemic lupus erythematosus based on new and traditional autoantibodies: demonstration of feasibility

–Annual European Congress of Rheumatology (EULAR) 2017
June 14, 2017

Multiparametric detection of autoantibodies to investigate relationships between serological and clinical subsets of systemic sclerosis patients

–Annual European Congress of Rheumatology (EULAR) 2017
June 14, 2017

Serum autoantibody profiling of primary Sjögren’s syndrome patients reveals novel biomarkers associated with the disease, disease activity, and clinical response to VAY736

–Annual European Congress of Rheumatology (EULAR) 2017
May 01, 2017

Tumor-associated autoantibodies: re-optimization of EarlyCDT®—Lung diagnostic performance and its application to indeterminate pulmonary nodules.

–Journal of Cancer Therapy
April 01, 2017

Implementing liquid biopsies into clinical decision making for cancer immunotherapy

–Oncotarget
April 01, 2017

Multivariate binary classification of imbalanced datasets—A case study based on high‐dimensional multiplex autoimmune assay data

–Biometrical Journal
March 27, 2017

Autoantibody signature enhances the positive predictive power of computed tomography for detection of lung cancer.

–Journal of Thoracic Oncology
March 01, 2017

Detection in blood of autoantibodies to tumour antigens as a case-finding method in lung cancer using the EarlyCDT®—Lung Test (ECLS): study protocol for a randomized controlled trial.

–BMC Cancer
March 01, 2017

Autoantibodies: opportunities for early cancer detection.

–Trends in Cancer
November 16, 2016

Discovery of novel autoantigens in Sjögren’s Syndrome with potential for subgrouping of disease

–American College of Rheumatology (ACR) annual meeting 2016
November 16, 2016

High-throughput screening discovers multiple novel autoantibodies in rheumatoid arthritis, systemic lupus, systemic sclerosis and Sjogren’s disease

–American College of Rheumatology (ACR) annual meeting 2016
November 16, 2016

Discovery and subsequent diagnostic verification of autoantibodies against the major vault protein (MVP) in systemic lupus Erythematosus

–American College of Rheumatology (ACR) annual meeting 2016
November 16, 2016

Identifying and assessing subgroups in systemic sclerosis patients based on comprehensive autoantibody profiling

–American College of Rheumatology (ACR) annual meeting 2016
November 16, 2016

The novel anti-BICD2 autoantibody potentially predicts a favorable disease course in systemic sclerosis

–American College of Rheumatology (ACR) annual meeting 2016
November 13, 2016

An RCT of the detection of autoantibodies to tumor antigens in lung cancer using the EarlyCDT®—Lung Test in Scotland (ECLS) in 12 208 study subjects.

–Journal of Thoracic Oncology
October 18, 2016

Analysis of the Early CDT-blood biomarker for lung cancer in higher vs. lower risk cohorts.

–Journal of Thoracic Oncology
October 10, 2016

Improvement in performance of an autoantibody panel test for detection of lung cancer by addition of a single novel biomarker (EDB1).

–Journal of Thoracic Oncology
October 05, 2016

Discovery and initial validation of autoantibodies against the major vault protein (MVP) in systemic lupus erythematosus

–European Lupus meeting 2016
October 05, 2016

Multiparametric detection of autoantibodies in Systemic Lupus Erythematosus (SLE) enables definition of SLE Patient Subgroups

–European Lupus meeting 2016
September 19, 2016

Quantitative, multiplex and label-free detection of Sjögren’s syndrome autoantibodies on the arrayed imaging reflectometry platform

–Biomarkers and Targeted Therapeutics in Sjögren’s 2016
September 01, 2016

Sequential high-content profiling of the IgG-autoantibody repertoire reveals novel antigens in rheumatoid arthritis

–Arthritis Research & Therapy
July 01, 2016

Multiparametric detection of autoantibodies in systemic lupus erythematosus

–Lupus
July 01, 2016

Comparison of pre-processing methods for multiplex bead-based immunoassays

–BMC Genomics
June 10, 2016

High-throughput screening discovers novel autoantibodies in autoimmune diseases: The SeroTag approach in systemic lupus, systemic sclerosis and rheumatoid arthritis

–Annual European Congress of Rheumatology (EULAR) 2016
June 08, 2016

Validation of 3 novel biomarker candidates for systemic sclerosis

–Annual European Congress of Rheumatology (EULAR) 2016
June 08, 2016

Confirmation of serological antibodies against novel citrullinated proteins in early rheumatoid arthritis

–Annual European Congress of Rheumatology (EULAR) 2016
February 01, 2016

Serum Autoantibodies in Chronic Prostate Inflammation in Prostate Cancer Patients

–PLOS One
February 01, 2016

Serum Autoantibodies in Chronic Prostate Inflammation in Prostate Cancer Patients

–PLOS One
November 06, 2015

Validation of novel biomarker candidates for systemic sclerosis

–American College of Rheumatology (ACR) annual meeting 2015
September 23, 2015

Development of a qualitative ELISA for the detection of anti-BICD2 autoantibodies in systemic sclerosis

–12th Dresden Symposium on Autoantibodies 2015
September 21, 2015

Screening for lung cancer with the Early CDT-Lung and computed tomography.

–Journal of Thoracic Oncology
September 07, 2015

Progress with an RCT of the detection of autoantibodies to tumour antigens in lung cancer using the EarlyCDT®—Lung test in Scotland (ECLS).

–Journal of Thoracic Oncology
September 02, 2015

Identification of homogeneous systemic lupus erythematosus (SLE) patient groups using clustered autoantibody reactivities

–Lupus 2015
July 01, 2015

A multicenter photoprovocation study to identify potential biomarkers by global peptide profiling in cutaneous lupus erythematosus

–Lupus
June 10, 2015

Identification of novel scleroderma–associated antigens and development of an autoantibody assay panel enabling their subsequent validation

–Annual European Congress of Rheumatology (EULAR) 2015
June 10, 2015

Discovery and validation of new autoantibody biomarker in systemic lupus erythematosus

–Annual European Congress of Rheumatology (EULAR) 2015
June 10, 2015

Autoantibody profiling of late and early RA patients against citrullinated proteins

–Annual European Congress of Rheumatology (EULAR) 2015
May 19, 2015

Improvement in the performance of the EarlyCDT®—Lungtest in the detection of lung cancer by the application of additional metrics to reduce false positive results.

–2015 ATS Annual Meeting, Am J Respir Crit Care Med
May 18, 2015

Measuring the improvement in lung nodule cancer risk assessment when EarlyCDT®—Lung is applied to a clinically-tested high-risk cohort.

–2015 ATS Annual Meeting, Am J Respir Crit Care Med
February 16, 2015

Development of a serum autoantibody assay to help with the detection of hepatocellular carcinoma.

–7th Annual International Liver Cancer Association (ILCA)
February 15, 2015

Serum antibodies in ovarian cancer.

–Molecular Med Tri-Con 2015
November 14, 2014

Development and validation of a diagnostic bead-based multiplex autoantibody assay: screening for autoantibodies to detect “Seronegative” rheumatoid arthritis

–American College of Rheumatology (ACR) Annual Meeting 2014
August 01, 2014

Serum autoantibody measurement for the detection of hepatocellular carcinoma.

–PLOS One
March 26, 2014

Development of a connective tissue disease array for differential diagnosis of ana-positive patients

–International Congress on Autoimmunity 2014
March 26, 2014

Validation of an autoantibody signature for the diagnosis of rheumatoid arthritis in an independent cohort

–International Congress on Autoimmunity 2014
March 26, 2014

Identification of subgroups of systemic lupus erythematosus patients based on autoantibody profiling

–International Congress on Autoimmunity 2014
October 25, 2013

Diagnostic autoantibody signatures of rheumatoid arthritis patients identified with a bead-based assay approach

–American College of Rheumatology (ACR) annual meeting 2013
October 25, 2013

Identification of novel distinct autoantigen clusters reflecting the heterogeneity of systemic lupus erythematosus

–American College of Rheumatology (ACR) annual meeting 2013
October 25, 2013

Autoantibody profiles predict responsiveness to methotrexate and anti-TNF therapy in early rheumatoid arthritis

–American College of Rheumatology (ACR) annual meeting 2013
October 14, 2013

Autoantibodies to a panel of lung cancer-associated antigens can provide significant discrimination between malignant and non-malignant lung nodules.

–WCLC 2013
October 02, 2013

Analysis of autoantibody signatures of neuromyelitis optica using protein arrays

–European Committee for Treatment and Research in Multiple Sclerosis Congress 2013
October 01, 2013

Audit of the autoantibody test, EarlyCDT®—Lung, in 1600 patients: an evaluation of its performance in routine clinical practice.

–Lung Cancer Journal
October 01, 2013

Signal stratification of autoantibody levels in serum samples and its application to the early detection of lung cancer.

–Journal of Thoracic Disease
September 05, 2013

Changes in autoantibody profiles in individuals with, and at risk for, hepatocellular carcinoma.

–7th Annual International Liver Cancer Association (ILCA)
September 01, 2013

An Audit of the clinical performance of EarlyCDT®—Lung.

–Chicago Multidisciplinary Symposium in Thoracic Oncology (ASTRO)
August 23, 2013

Signal stratification of autoantibody levels in serum samples and its application to the early diagnosis of lung cancer.

–Am J Respir Crit Care Med
December 01, 2012

Application of a high throughput method of biomarker discovery to improvement of the EarlyCDT®—Lung test.

–PLOS One
November 01, 2012

Challenges in biomarker development.

–World Breast Cancer Report 2012
October 24, 2012

Benefits of using EarlyCDT®—Lung in clinical practice.

–Chest
October 24, 2012

The additive effect of the stratified EarlyCDT®—Lung serum autoantibody test on the assessment of lung cancer risk.

–Chest
October 21, 2012

EarlyCDT®—Lung enhances the positive predictive power of computed tomography for detecting lung cancer.

–Chest
October 10, 2012

Early identification of hepatocellular carcinoma.

–ISOBM 2012, Tumor Biology
October 05, 2012

Early identification of lung cancer using autoantibody assays.

–40th Congress of the International-Society-of-Oncology-and-Biomarkers, Volume: 33
July 24, 2012

Development and validation of a high throughput system for discovery of antigens for autoantibody detection.

–PLOS One
May 10, 2012

Identification of tumor-associated autoantibodies to different forms of recombinant MAGE A4.

–American Journal of Respiratory and Critical Care Medicine
May 01, 2012

Identification of tumour-associated autoantibodies in small-cell lung cancer as immune markers of disease.

–ISOBM 2012, Tumor Biology
May 01, 2012

Improved specificity of the EarlyCDT®—Lung test through additional autoantibody assays.

–American Journal of Respiratory and Critical Care Medicine
April 01, 2012

EarlyCDT®—Lung test: improved clinical utility through additional autoantibody assays.

–Tumour Biology
December 06, 2011

Serum autoantibodies to breast cancer associated antigens reflect tumour biology: an opportunity for early detection & prevention?

–Cancer Research Special Supplement
October 31, 2011

Autoantibodies as immunobiomarkers in lung cancer and their use in early cancer detection.

–Tumor Biology Supplement
October 09, 2011

Autoantibodies to p53 can predate a clinical diagnosis of ovarian cancer – a case report.

–Tumor Biology Supplement
October 09, 2011

Autoantibodies in ovarian cancer.

–Tumor Biology Supplement
September 05, 2011

The utility of SOX antibodies for cancer prediction in patients with paraneoplastic neurological disorders.

–Association of British Neurologists Annual Meeting 2011
July 01, 2011

EarlyCDT®—Lung test: audit of the first 1000 patients in clinical practice.

–IASLT Amsterdam
May 18, 2011

Mesothlioma and tumor-associated autoantibodies.

–Am J Respir Crit Care Med
May 17, 2011

Demonstration of the specificity of human autoantibody responses to tumor associated antigens.

–Am J Respir Crit Care Med
May 16, 2011

Cost-effectiveness of screening older adult smokers for lung cancer with an autoantibody test (AABT).

–Am J Respir Crit Care Med
May 16, 2011

EarlyCDT®—Lung: a newly marketed blood test to aid the early detection of lung cancer in high-risk patients – enhances the positive predictive power of computed tomography.

–Am J Respir Crit Care Med
March 05, 2011

EarlyCDT®—Lung: an immuno-biomarker test as an aid to early detection of lung cancer.

–Cancer Prevention Research
December 11, 2010

Immuno-biomarkers in small cell lung cancer: potential early clinical signals.

–Clinical Cancer Research
December 01, 2010

An improved EarlyCDT®—Lung test can be used to aid the detection of lung cancer.

–Chicago Multidisciplinary Symposium in Thoracic Oncology (ASTRO)
October 11, 2010

Antigen positivity in the Early CDT—Lung test by stage and histological subtype of lung cancer.

–Chest
October 10, 2010

The presence of autoantibodies to tumour-associated antigens can predate clinical diagnosis of lung cancer (CHEST 2010).

–Chest
October 09, 2010

Autoantibodies in oncology – presence and use for early disease identification.

–XIII International Symposium on Biology and Clinical Usefulness of Tumor Markers – Barcelona
October 01, 2010

Stage 1a non-small cell lung cancer detected by assaying autoantibodies to tumor antigens.

–Chest
October 01, 2010

EarlyCDT®—Lung: QC measures reveal high precision, accuracy and robustness of a clinical test to aid in early lung cancer detection for high-risk individuals.

–Chest
October 01, 2010

An autoantibody test (AABT) to aid in early detection of lung cancer in high-risk patients is likely to be cost-effective.

–Chest
October 01, 2010

Reproducibility of autoantibody measurements in normal individuals using the EarlyCDT®—Lung test.

–Chest
September 19, 2010

The presence of autoantibodies to tumour-associated antigens can predate clinical diagnosis of lung cancer.

–Tumor Biology Supplement
September 19, 2010

Does heat treatment of human serum affect the measurement of autoantibodies to recombinant tumour-associated antigens?

–Tumor Biology Supplement
July 03, 2010

Clinical validation of an autoantibody test for lung cancer.

–Annals of Oncology
June 15, 2010

Demographics of populations at high risk of lung cancer and results of the EarlyCDT®—Lung test.

– Journal of Clinical Oncology, ASCO
June 04, 2010

Cost-effectiveness of an Autoantibody Test (AABT) as an aid to diagnosis of lung cancer.

–Journal of Clinical Oncology, ASCO
June 04, 2010

Use of sSerum autoantibodies to identify early-stage lung cancer: a significant step forward in early detection.

–Journal of Clinical Oncology, ASCO
May 12, 2010

Cancer testis antigen vaccination affords long-term protection in a murine model of ovarian cancer.

–PLOS One
April 29, 2010

Autoimmunity to SOX2, clinical phenotype and survival in patients with small-cell lung cancer.

–Lung Cancer Journal
February 17, 2010

Technical validation of an autoantibody test for lung cancer.

–Annals of Oncology
September 24, 2008

A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression.

–Glycobiology
August 30, 2008

Lung cancer – can autoantibodies provide an aid to diagnosis?

–Expert Opinion on Medical Diagnostics
March 30, 2008

Autoantibodies in lung cancer – possibilities for early detection and subsequent cure.

–Thorax
March 01, 2008

The O-linked glycosylation of secretory/shed MUC1 from an advanced breast cancer patient’s serum.

–Glycobiology
January 01, 2008

Removal Of major bacterial contaminant SlyD after a two-step chromatography purification of recombinant protein.

–Peptalk
November 17, 2007

Serum EGFR and HER-2 expression in primary and metastaic breast cancer.

–Breast Cancer Research
September 07, 2007

Bacterial contaminant removal after purification of recombinant protein.

–BioProcess International
June 26, 2007

Two-step method to isolate target recombinant protein from co-purified bacterial contaminant SlyD after immobilised metal affinity chromatography.

–Journal of Chromatography
March 02, 2007

Autoantibodies in breast cancer: their use as an aid to early diagnosis.

–Annals of Oncology
September 22, 2006

Comparison of the autoantibody reactivity of the extracellular and intracellular domains of the tumour antigen HER-2 in breast cancer diagnosis.

–Tumor Biology Supplement
September 16, 2006

Serum vs. plasma in autoantibody detection by ELISA.

–ISOBM 2006. Pasadena, Calif. for Oncodevelopmental Biology and Medicine, ISOBM 2006 September 16–20, 2006, Pasadena, Calif
September 01, 2006

Autoantibodies in breast cancer: their use as an aid to early diagnosis.

–Tumor Biology Supplement
April 16, 2006

Use of autoantibodies in breast cancer screening and diagnosis.

–Expert Review of Anticancer Therapy
October 15, 2005

Malignancy-induced autoimmunity to MUC1: initial antibody characterization.

–Journal of Peptide Research
October 01, 2005

Autoantibodies in lung cancer.

–Tumor Biology Supplement
September 27, 2005

Serum MUC1 O-glycans from cancer patients contain the Sialyl Tn antigen.

–Tumor Biology Supplement
September 20, 2005

Human autoantibodies to CA125.

–Tumor Biology Supplement